View in EDS HTML Full Text PDF Full Text

Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's disease.

Saved in:
Bibliographic Details
Title: Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's disease.
Authors: Ben Bashat D; Sagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. dafnab@tlvmc.gov.il.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. dafnab@tlvmc.gov.il.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. dafnab@tlvmc.gov.il., Thaler A; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Laboratory of Early Markers Of Neurodegeneration (LEMON), Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Lerman Shacham H; Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel., Even-Sapir E; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel., Hutchison M; Biogen Inc., Cambridge, MA, USA., Evans KC; Biogen Inc., Cambridge, MA, USA., Orr-Urterger A; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Genomic Research Laboratory for Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Cedarbaum JM; Coeruleus Clinical Sciences LLC, Woodbridge, CT, USA.; Yale University School of Medicine, New Haven, CT, USA., Droby A; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Laboratory of Early Markers Of Neurodegeneration (LEMON), Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Giladi N; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Laboratory of Early Markers Of Neurodegeneration (LEMON), Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Mirelman A; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Laboratory of Early Markers Of Neurodegeneration (LEMON), Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Artzi M; Sagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Source: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2022 Oct 21; Vol. 8 (1), pp. 139. Date of Electronic Publication: 2022 Oct 21.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101675390 Publication Model: Electronic Cited Medium: Print ISSN: 2373-8057 (Print) Linking ISSN: 23738057 NLM ISO Abbreviation: NPJ Parkinsons Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36271084
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neuromelanin and T<subscript>2</subscript>*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ben+Bashat+D%22">Ben Bashat D</searchLink>; Sagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. dafnab@tlvmc.gov.il.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. dafnab@tlvmc.gov.il.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. dafnab@tlvmc.gov.il.<br /><searchLink fieldCode="AU" term="%22Thaler+A%22">Thaler A</searchLink>; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Laboratory of Early Markers Of Neurodegeneration (LEMON), Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Lerman+Shacham+H%22">Lerman Shacham H</searchLink>; Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Even-Sapir+E%22">Even-Sapir E</searchLink>; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Hutchison+M%22">Hutchison M</searchLink>; Biogen Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Evans+KC%22">Evans KC</searchLink>; Biogen Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Orr-Urterger+A%22">Orr-Urterger A</searchLink>; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Genomic Research Laboratory for Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Cedarbaum+JM%22">Cedarbaum JM</searchLink>; Coeruleus Clinical Sciences LLC, Woodbridge, CT, USA.; Yale University School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Droby+A%22">Droby A</searchLink>; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Laboratory of Early Markers Of Neurodegeneration (LEMON), Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Giladi+N%22">Giladi N</searchLink>; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Laboratory of Early Markers Of Neurodegeneration (LEMON), Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Mirelman+A%22">Mirelman A</searchLink>; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; Laboratory of Early Markers Of Neurodegeneration (LEMON), Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Artzi+M%22">Artzi M</searchLink>; Sagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101675390%22">NPJ Parkinson's disease</searchLink> [NPJ Parkinsons Dis] 2022 Oct 21; Vol. 8 (1), pp. 139. <i>Date of Electronic Publication: </i>2022 Oct 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101675390 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2373-8057 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223738057%22">23738057 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Parkinsons Dis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36271084
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41531-022-00405-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 139
    Titles:
      – TitleFull: Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ben Bashat D
      – PersonEntity:
          Name:
            NameFull: Thaler A
      – PersonEntity:
          Name:
            NameFull: Lerman Shacham H
      – PersonEntity:
          Name:
            NameFull: Even-Sapir E
      – PersonEntity:
          Name:
            NameFull: Hutchison M
      – PersonEntity:
          Name:
            NameFull: Evans KC
      – PersonEntity:
          Name:
            NameFull: Orr-Urterger A
      – PersonEntity:
          Name:
            NameFull: Cedarbaum JM
      – PersonEntity:
          Name:
            NameFull: Droby A
      – PersonEntity:
          Name:
            NameFull: Giladi N
      – PersonEntity:
          Name:
            NameFull: Mirelman A
      – PersonEntity:
          Name:
            NameFull: Artzi M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 10
              Text: 2022 Oct 21
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2373-8057
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ Parkinson's disease
              Type: main
ResultId 1